6 Drug Stocks Unworthy of Biotech Bull Market

Description:

According to Adam Feuerstein, here are "six biotech and drug stocks with valuations reaching unsustainable levels or which, for various reasons, don't deserve an invitation to the biotech bull market party at all." Read more here.

>>Also: 6 Stocks With Double-Digits Gains and Big Dividends

>>Also: 3 Tech Turnaround Stocks for 2012

Most Viewed Portfolios

View All

Articles

A Small Stocks to Play the Ukraine Crisis

04.16.14 | 02:17 PM

DELAFIELD, Wis. (Stockpickr) -- Energy has some energy in this shaky equity market. >>5 Stocks Set to Soar on Bullish Earnings In contrast to al...

5 Stocks Insiders Love Right Now

04.16.14 | 01:08 PM

DELAFIELD, Wis. (Stockpickr) -- Corporate insiders sell their own companies' stock for a number of reasons. >>5 Stocks Set to Soar on Bullish Ear...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter